HDL Diagnostics Overview

  • Founded
  • 2015
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

HDL Diagnostics General Information


Developer of medical assays and bio markers designed to offer treatment for cardiovascular diseases. The company's products help in identifying cardiac diseases and offer a system for its efficient treatment, as well as focus on research and development of high-density lipoproteins for production of cardiovascular drugs, enabling cardiac patients to get advanced treatment for their diseases and recover fast.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Services
Drug Discovery
Primary Office
  • 118 West Bergen Drive
  • Fox Point, WI 53217
  • United States
+1 (414) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HDL Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Apr-2018 Completed Out of Business
1. Early Stage VC Completed Startup
To view HDL Diagnostics’s complete valuation and funding history, request access »

HDL Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Kirkwood Pritchard Chief Scientific Officer
You’re viewing 1 of 2 executive team members. Get the full list »

HDL Diagnostics Board Members (1)

Name Representing Role Since
Andrew Shrago Self Board Member 000 0000
To view HDL Diagnostics’s complete board members history, request access »